Abstract:Normal hematopoiesis requires the accurate orchestration of lineage-specific patterns of gene expression at each stage of development, and epigenetic regulators play a vital role. Disordered epigenetic regulation has emerged as a key mechanism contributing to hematological malignancies. Histone deacetylases (HDACs) are a series of key transcriptional cofactors that regulate gene expression by deacetylation of lysine residues on histone and nonhistone proteins. In normal hematopoiesis, HDACs are widely involved in the development of various lineages. Their functions involve stemness maintenance, lineage commitment determination, cell differentiation and proliferation, etc. Deregulation of HDACs by abnormal expression or activity and oncogenic HDAC-containing transcriptional complexes are involved in hematological malignancies. Currently, HDAC family members are attractive targets for drug design, and a variety of HDAC-based combination strategies have been developed for the treatment of hematological malignancies. Drug resistance and limited therapeutic efficacy are key issues that hinder the clinical applications of HDAC inhibitors (HDACis). In this review, we summarize the current knowledge of how HDACs and HDAC-containing complexes function in normal hematopoiesis and highlight the etiology of HDACs in hematological malignancies. Moreover, the implication and drug resistance of HDACis are also discussed. This review presents an overview of the physiology and pathology of HDACs in the blood system.

Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis

Role of HDACs in normal and malignant hematopoiesis

The emerging roles of HDACs and their therapeutic implications in cancer

Targeting histone deacetylases: Emerging applications beyond cancer

Histone Deacetylases in Modulating Cardiac Disease and Their Clinical Translational and Therapeutic Implications

The Role Of Histone Acetyltransferases In Normal And Malignant Hematopoiesis

Histone deacetylase function in CD4+ T cells

Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability

Advances in the Application of Histone Deacetylase Inhibitors in Eye Disease

Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis.

The role of histone deacetylases in embryonic development

Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins

The Structure and Function of Histone Deacetylases: the Target for Anti-cancer Therapy

Targeting histone deacetylases for cancer therapy: from molecular mechanisms to clinical implications.

Histone Deacetylases in Metabolism: The Known and the Unexplored

The Roles of Histone Deacetylases and Their Inhibitors in Cancer Therapy

Roles of Histone Deacetylases in Epigenetic Regulation: Emerging Paradigms from Studies with Inhibitors

Histone deacetylase inhibitors: targeting epigenetic regulation in the treatment of acute leukemia

Histone deacetylases: Regulation of vascular homeostasis via endothelial cells and vascular smooth muscle cells and the role in vascular pathogenesis

Exploring the role of histone deacetylase inhibitors in cancer development and therapeutic potential

A short guide to histone deacetylases including recent progress on class II enzymes